Chronic Ambulatory Peritoneal Dialysis

The past several years have seen a rising tide of discontent with many aspects of the otherwise quite successful federal End-Stage Renal-Disease Program. Societal concern over the declining percentage of patients receiving treatment at home, the ballooning costs of the program, the wide variability in dialysis rates from state to state, and the increasing number of patients overall has been discussed extensively in the Journal.1 2 3 In addition to these broader social and economic problems, important medical problems also persist, including a continued high rate of rejection in recipients of cadaveric grafts and an excessive rate of infection in all . . .